$PTIX Income Statement | Understand Stock

$PTIX

$0.74 +$0.00 (0.0%) Close

Financial Statements

In USD, except per-share amounts

	FY2026 12 months to Mar 31, 2026	FY2025 12 months to Dec 31, 2024	FY2024 12 months to Dec 31, 2023	FY2023 12 months to Dec 31, 2022	FY2022 12 months to Dec 31, 2021
OPERATING EXPENSES:
Accounting and audit fees
Research and Development
Research and development – related party
Legal Fees
Consulting Fees
Salaries and wages
General and administrative - other
Stock compensation
TOTAL OPERATING EXPENSES
LOSS FROM OPERATIONS
OTHER INCOME (EXPENSES):
Interest income
Interest expense
Realized loss on marketable securities
Gain on settlement of accounts payable and accrued liabilities with Related parties
Interest expenses
Derivative expense
Change in fair value of derivative liabilities
Foreign currency exchange differences
Gain/loss on disposal of subsidiary
Gain/loss on extinguishment of debt
TOTAL OTHER INCOME (EXPENSE)
INCOME (LOSS) BEFORE INCOME TAXES
NET INCOME (LOSS)
Other comprehensive gain (loss):
Net unrealized gain (loss) on marketable securities
Reclassification of realized losses on debt securities
Foreign exchange translation income (loss)
Unrealized foreign currency translation loss
Shares issued in connection with Phytanix Bio purchase
Comprehensive income (loss)
Net loss per common share - Basic and Diluted
Weighted average common shares - Basic and Diluted
NET INCOME (LOSS) PER SHARE:
Basic
Diluted
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING:
Basic
Diluted

Comments